BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:2023 is booming with novel psychiatric R AND D and the promise
  of precision medicine for neuropsychiatric patients. Pipelines are gaini
 ng momentum\, with notable approvals on the horizon\, as unmet needs in P
 TSD\, bipolar\, anxiety\, schizophrenia\, depression\, and ADHD become gr
 eater and greater. There is\, therefore\, a huge deal of novel and promis
 ing research to be discussed this October at the 6th Neuropsychiatric Dru
 g Development Summit.\n\nWith discovery\, preclinical\, translational\, a
 nd clinical scientists from the likes of Biogen\, Otsuka\, AbbVie\, Genen
 tech\, Lundbeck\, Delix Therapeutics\, Atai\, Gilgamesh\, and Cerevel The
 rapeutics\, don't miss the field's favorite conference\, specifically ded
 icated to biopharma's most pressing challenges of de-risking the translat
 ional gap and advancing transformative neuropsychiatric candidates throug
 h the clinic.\n
DTEND:20231012T170000
DTSTAMP:20260512T220330Z
DTSTART:20231010T080000
LOCATION:Hilton Boston Back Bay\, 40\, Dalton Street\, Boston\, Suffolk Co
 unty\, 02115\,
SEQUENCE:0
SUMMARY:2023 is booming with novel psychiatric R AND D and the promise of 
 precision medicine for neuropsychiatric patients. Pipelines are gaining m
 omentum\,...
UID:4919246f-255e-4319-b75f-5e0cf67e475a
END:VEVENT
END:VCALENDAR